Condition

FSGS (3)

Focal Segmental Glomerulosclerosis (3)

MCD (3)

Minimal Change Disease (3)

MCD - Minimal Change Disease (1)

Membranous Nephropathy (1)

Minimal Change Nephrotic Syndrome (1)

Nephrotic Syndrome in Children (1)

Overall Status

Enrolling by invitation (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

University of Michigan (3)

Collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

New York University (1)

Intervention

adalimumab (1)

biospecimen collection (1)

communication (1)

data collection (1)

Study Documents

Intervention Type

other (2)

drug (1)

Funder Type

Other (3)

Study Type

Observational (2)

Interventional (1)

mcd

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

NEPTUNE Match Study

Enrolling by invitation

Nephrotic Syndrome in Children
+7 more

Communication

Atlanta, Georgia
+15 more

Jan 30, 2023

Focal Segmental Glomerulosclerosis and Minimal Change Disease

Not yet recruiting

Focal Segmental Glomerulosclerosis
+3 more

Biospecimen collection
Data collection

Ann Arbor, Michigan

University of Michigan

Dec 6, 2022

FSGS, MCD, Focal Segmental Glomerulosclerosis Trial in United States (adalimumab)

Recruiting

FSGS
+3 more

adalimumab

Ann Arbor, Michigan
+3 more

Jan 31, 2022